avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou2f3
|
ENSMUSG00000032015.9 | POU domain, class 2, transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pou2f3 | mm10_v2_chr9_-_43205755_43205885 | 0.29 | 8.8e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
1.3 | 4.0 | GO:0015811 | L-cystine transport(GO:0015811) |
1.1 | 3.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.9 | 10.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.8 | 2.5 | GO:0015866 | ADP transport(GO:0015866) |
0.8 | 3.1 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.8 | 3.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.7 | 2.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.7 | 5.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 1.9 | GO:0090265 | immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
0.4 | 1.3 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.4 | 5.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.2 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.4 | 1.5 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.3 | 3.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 1.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 3.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 2.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 2.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 0.8 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 4.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.2 | 1.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.7 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) |
0.2 | 3.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 1.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 8.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.2 | 0.6 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.2 | 4.0 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 1.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 2.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 1.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 2.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 0.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 1.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 1.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 2.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 1.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 1.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:1990705 | T-helper 1 cell lineage commitment(GO:0002296) cholangiocyte proliferation(GO:1990705) |
0.1 | 0.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 1.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.4 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.5 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.1 | 0.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 0.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.5 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.3 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 1.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 1.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 1.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 1.5 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.4 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.3 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.7 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 1.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 1.1 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.7 | GO:0061470 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
0.1 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 1.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.8 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 1.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.5 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 1.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.3 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 1.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.9 | GO:0008210 | luteinization(GO:0001553) estrogen metabolic process(GO:0008210) |
0.0 | 0.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.0 | 1.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 1.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 1.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) Notch signaling involved in heart development(GO:0061314) |
0.0 | 5.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.2 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 1.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 1.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 1.3 | GO:0000910 | cytokinesis(GO:0000910) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0005940 | septin ring(GO:0005940) |
0.5 | 8.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 2.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 3.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 5.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 1.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.5 | GO:0071920 | cleavage body(GO:0071920) |
0.1 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 2.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 5.3 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 2.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.2 | GO:0005713 | recombination nodule(GO:0005713) |
0.1 | 0.2 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.1 | 0.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.0 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.3 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 16.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 1.3 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 2.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 1.3 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 1.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 2.1 | GO:0031012 | extracellular matrix(GO:0031012) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.3 | GO:0002113 | interleukin-33 binding(GO:0002113) |
1.3 | 4.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.0 | 6.8 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.7 | 4.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.6 | 1.9 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.4 | 1.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 1.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.4 | 8.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 2.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 2.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 1.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.3 | 3.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.7 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.2 | 0.9 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.2 | 2.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 3.3 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.5 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.2 | 2.2 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 9.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 1.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 1.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.4 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.1 | 7.2 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.1 | 1.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.5 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 5.0 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 0.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.1 | 1.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 1.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.1 | 0.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 2.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 1.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.0 | 1.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 10.1 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 1.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 1.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 4.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 1.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 2.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.6 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 1.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 3.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 5.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 5.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 3.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.3 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 4.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 5.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 7.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 3.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 0.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 2.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 2.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 3.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 2.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.8 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 2.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 2.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 2.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |